Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 80303

12 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
June 14, 2018
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
SCA Pharmaceuticals, LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

12 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 12

Morphine Sulfate 1 mg/mL (preservative free; sulfite free) 2 mL fill 3 mL syringe, SCA Pharmaceuticals, LLC, Windsor, CT

D-0894-2018
Recall number
D-0894-2018
Initiated
June 14, 2018
Classification
Class II
Status
Terminated
Recalling firm
SCA Pharmaceuticals, LLC
Quantity
440 syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Code information

Lot # 20180323@44, Exp 06/21/2018

Distribution pattern

Product was distributed throughout the United States.

drug · product 2 of 12

Fentanyl (as citrate) 10 mcg/mL in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT

D-0895-2018
Recall number
D-0895-2018
Initiated
June 14, 2018
Classification
Class II
Status
Terminated
Recalling firm
SCA Pharmaceuticals, LLC
Quantity
492 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Code information

Lot # 20180328@19, 20180328@31, 20180328@39, 20180328@49, 20180328@53, 20180328@58, 20180323@9, 20180327@33, Exp 6/26/2018

Distribution pattern

Product was distributed throughout the United States.

drug · product 3 of 12

Fentanyl (as citrate) 2 mcg/mL + Bupivacaine HCL 0.0625% in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT

D-0896-2018
Recall number
D-0896-2018
Initiated
June 14, 2018
Classification
Class II
Status
Terminated
Recalling firm
SCA Pharmaceuticals, LLC
Quantity
179 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Code information

Lot # 20180327@27, 20180327@40, 20180328@9, Exp 06/28/2018

Distribution pattern

Product was distributed throughout the United States.

drug · product 4 of 12

Diltiazem HCL 1 mg/mL in 125 mL 0.9% Sodium Chloride 100 mL bag (total volume 125 mL) (125 mg), SCA Pharmaceuticals, LLC, Windsor, CT

D-0897-2018
Recall number
D-0897-2018
Initiated
June 14, 2018
Classification
Class II
Status
Terminated
Recalling firm
SCA Pharmaceuticals, LLC
Quantity
2,869 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Code information

Lot # 1218001315, 1218001316, 1218001349, 1218001416, 1218001510, 1218001682, 1218001683, 1218001684, 1218001721, 1218001763, 1218001764, Exp 07/26/2018-08/27/2018

Distribution pattern

Product was distributed throughout the United States.

drug · product 5 of 12

Norepinephrine Bitartrate 4 mg (16 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT

D-0898-2018
Recall number
D-0898-2018
Initiated
June 14, 2018
Classification
Class II
Status
Terminated
Recalling firm
SCA Pharmaceuticals, LLC
Quantity
2,268 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Code information

Lot # 1218000928, 1218000944, 1218000945, 1218001075, 1218001076, 1218001188, Exp 06/19/2018-07/03/2018

Distribution pattern

Product was distributed throughout the United States.

drug · product 6 of 12

Norepinephrine Bitartrate 8 mg (32 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT

D-0899-2018
Recall number
D-0899-2018
Initiated
June 14, 2018
Classification
Class II
Status
Terminated
Recalling firm
SCA Pharmaceuticals, LLC
Quantity
1,882 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Code information

Lot # 1218000930, 1218000946, 1218001058, 1218001077, 1218001169, 1218001170, 1218001190, 1218001191, 1218001206, 1218001317, Exp 06/18/2018-07/11/2018

Distribution pattern

Product was distributed throughout the United States.

drug · product 7 of 12

Norepinephrine Bitartrate 16 mg (64 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT

D-0900-2018
Recall number
D-0900-2018
Initiated
June 14, 2018
Classification
Class II
Status
Terminated
Recalling firm
SCA Pharmaceuticals, LLC
Quantity
1,397 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Code information

Lot # 1218000677, 1218000947, 1218000982, 1218001018, 1218001029, 1218001059, 1218001060, 1218001078, 1218001079, 1218001171, 1218001172, 1218001192, 1218001193, 1218001207, 1218001209, 1218001210, Exp 06/19/2018-07/03/2018

Distribution pattern

Product was distributed throughout the United States.

drug · product 8 of 12

Phenylephrine HCL 10 mg in 0.9% Sodium Chloride 250 mL Bag (40 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT

D-0901-2018
Recall number
D-0901-2018
Initiated
June 14, 2018
Classification
Class II
Status
Terminated
Recalling firm
SCA Pharmaceuticals, LLC
Quantity
451 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Code information

Lot # 20180323@24, Exp 06/21/2018

Distribution pattern

Product was distributed throughout the United States.

drug · product 9 of 12

Phenylephrine HCL 40 mg in 0.9% Sodium Chloride 250 mL Bag (160 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT

D-0902-2018
Recall number
D-0902-2018
Initiated
June 14, 2018
Classification
Class II
Status
Terminated
Recalling firm
SCA Pharmaceuticals, LLC
Quantity
451 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Code information

Lot # 20180323@24

Distribution pattern

Product was distributed throughout the United States.

drug · product 10 of 12

Phenylephrine HCL 20 mg in 0.9% Sodium Chloride 250 mL Bag (160 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT

D-0903-2018
Recall number
D-0903-2018
Initiated
June 14, 2018
Classification
Class II
Status
Terminated
Recalling firm
SCA Pharmaceuticals, LLC
Quantity
400 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Code information

Lot # 20180323@29, Exp 06/21/2018

Distribution pattern

Product was distributed throughout the United States.

drug · product 11 of 12

Phenylephrine HCL 50 mg in 0.9% Sodium Chloride 250 mL Bag (200 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT

D-0904-2018
Recall number
D-0904-2018
Initiated
June 14, 2018
Classification
Class II
Status
Terminated
Recalling firm
SCA Pharmaceuticals, LLC
Quantity
Unavailable

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Code information

Lot # 20180329@2, Exp 06/27/2018

Distribution pattern

Product was distributed throughout the United States.

drug · product 12 of 12

Phenylephrine HCL 80mg in 0.9% Sodium Chloride 250 mL Bag (320 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT

D-0905-2018
Recall number
D-0905-2018
Initiated
June 14, 2018
Classification
Class II
Status
Terminated
Recalling firm
SCA Pharmaceuticals, LLC
Quantity
196 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Code information

Lot # 20180328@25, Exp 06/26/2018

Distribution pattern

Product was distributed throughout the United States.

Field note

Send feedback

We'll only use this to respond to your feedback.